semaglutide and asthma As the role of #GLP1 therapies in #MASLD continues to grow, clinicians need clear guidance. A new Practice Guidance update in #HEPATOLOGY provides evidence-based recommendations on using therapy for MASH, including Variety:Quarterly Subscription Bone Heath retatrutide phase 2 nejm

semaglutide and asthma As the role of #GLP1 therapies in #MASLD continues to grow, clinicians need clear guidance. A new Practice Guidance update in #HEPATOLOGY provides evidence-based recommendations on using therapy for MASH, including Variety:Quarterly Subscription Bone Heath retatrutide phase 2 nejm

retatrutide phase 2 nejm weight loss 48 weeks triple agonist Triple–Hormone-Receptor for Obesity — A Trial | Retatrutide's July 23 Phase 3 –

This has led to increased interest in whether medications like Wegovy might offer additional support for weight loss in this patient population, whilst raising important questions about safety and potential interactions with thyroid function

Bone Heath

Variety:Quarterly Subscription

The best long-term data we have shows people regain two-thirds of their lost weight within two years of stopping